Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-comers Coronary Lesions (ULTIMATE Trial) (ULTIMATE)
Sponsor: Nanjing First Hospital, Nanjing Medical University
A NA clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Nanjing First Hospital, Nanjing Medical University and has accumulated 12 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2019 — Dec 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Sep 2018 — Oct 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jun 2017 — Oct 2017 [monthly]
Recruiting NA
-
May 2017 — Jun 2017 [monthly]
Recruiting NA
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nanjing First Hospital, Nanjing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .